glutamic acid and Mental Disorders

glutamic acid has been researched along with Mental Disorders in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	17 (18.89)	18.7374
1990's	5 (5.56)	18.2507
2000's	23 (25.56)	29.6817
2010's	39 (43.33)	24.3611
2020's	6 (6.67)	2.80

Authors

Authors	Studies
de la Torre, R; Flores-López, M; Gavito, AL; Pastor, A; Pavón, FJ; Rodríguez de Fonseca, F; Sánchez-Marín, L; Serrano, A; Suárez, J	1
Morland, C; Nordengen, K	1
Ao, R; Deng, J; Li, D; Li, N; Li, X; Liu, S; Long, Y; Ma, Y; Shi, A; Wan, J; Wen, J; Yu, S; Zhang, Y	1
Anastasio, NC; Cunningham, KA; Davis-Reyes, BD; Smith, AE; Xu, J; Zhou, J	1
Han, J; Shen, Y; Su, LD; Wang, N	1
Acquarone, M; Barbosa, HS; Gonçalves, PFR; Menezes, JRL; Neves, GA; Panizzutti, R; Perozzo, AF; Poleto, A	1
Abdallah, CG; Arnsten, AF; Averill, LA; Krystal, JH; Southwick, SM	1
Burns, SB; Luheshi, GN; Lutz, PE; Szyszkowicz, JK; Turecki, G	1
Auladell, C; Binvignat, O; Camins, A; Cornejo-Córdova, E; Olloquequi, J; Soriano, FX; Verdaguer, E	1
Chen, WB; Cui, WP; Dong, ZQ; Fei, EK; Figueiredo, D; Li, BM; Li, HW; Liu, F; Mei, L; Pan, BX; Robinson, H; Sun, XD; Wang, HS; Wang, YN; Xiong, WC	1
Barry, G; Bitar, M; Brennand, KJ; Guennewig, B; Hanks, J; Hurd, YL; Kaczorowski, DC; O'Brien, EA; Obiorah, I; Roussos, P	1
Aoki, J; Cheng, H; Distler, U; Endle, H; Geisslinger, G; Hauser, MJ; Horta, G; Kirischuk, S; Laube, G; Luhmann, HJ; Morris, AJ; Nitsch, R; Qiao, L; Radyushkin, K; Röper, J; Sigurdsson, T; Tegeder, I; Tenzer, S; Thalman, C; Vogt, J	1
Culmsee, C; Michels, S; Schwarting, RK; Wöhr, M	1
Kennedy, MB	1
Zhuo, M	1
Konen, C; Niederst, E	1
Falkai, P; Schmitt, A	1
de Bartolomeis, A; Iasevoli, F; Latte, G; Tomasetti, C	1
Lerma, J; Marques, JM	1
Bustillo, JR	1
Majláth, Z; Obál, I; Toldi, J; Vécsei, L	1
Alzweiri, M; Bardaweel, SK; Ishaqat, AA	1
Hutson, PH; Madhoo, M; Patkar, AA; Slawecki, C; Tarazi, FI	1
Borroni, E; Bruns, A; Kapps, M; Künnecke, B; Müller, S; Rudin, M; von Kienlin, M; Waschkies, CF	1
Biederman, J; Keary, CJ; Kenworthy, T; Spencer, AE; Uchida, M	1
Pin, JP; Rondard, P	1
Futamura, T; Hashimoto, K; Ohgi, Y	1
Ayers-Ringler, J; Benitez, J; Choi, DS; Lindberg, D; McCullumsmith, R; Oliveros, A; Prieto, M; Shan, D	1
Bertrand, D; Bertrand, S; Castillo-Gómez, E; Ehrenreich, H; Hollmann, M; Jurek, B; Klein-Schmidt, C; Oliveira, B; Pan, H; Prüss, H; Steiner, J; Tapken, D; Trippe, R; Zafeiriou, P; Zimmermann, WH	1
Huang, Q; Shen, Z; Wu, R; Xu, H; Zhang, H; Zhang, J	1
Parpura, V; Peng, L; Steardo, L; Verkhratsky, A	1
Chauhan, PS; Kalita, J; Misra, UK	1
Gajwani, R; Gross, J; Gumley, AI; Lawrie, SM; Schwannauer, M; Uhlhaas, PJ	1
Allen, PS; Gropman, AL; Harris, KC; Robertson, LW; Ross, BD; Sailasuta, N	1
Barker, GJ; Day, F; Lythgoe, DJ; McGuire, PK; McLean, MA; O'Gorman, RL; Stone, JM; Tsagaraki, H; Valli, I	1
Lopes, A; Quelhas, R	1
Tanaka, K	1
Kikuchi, T; Takeda, A; Tamano, H; Watanabe, M	1
Gielen, M	1
Bloss, EB; Hunter, RG	1
Carlezon, WA; Davis, M; Myers, KM	1
Agam, G; Ben-Shachar, D	1
Feuerstein, TJ; Kammerer, M; Lücking, CH; Moser, A	1
Cleva, RM; Kalivas, PW; Malcolm, RJ; Olive, MF	1
Nishikawa, T	1
Buonocore, MH; Maddock, RJ	1
Fagni, L	1
Berk, M; Data-Franco, J; Dean, OM; Giorlando, F	1
Baker, DA; Bridges, R; Lobner, D; Lutgen, V	1
Holden, C	1
Klosterkötter, J	1
BRADLEIOVA, M; VENCOVSKY, E	1
GIESE, H	1
NOURISSIER, MT; ROPERT, R	1
SCHWOBEL, G	1
LORAND, B	1
DULCE, HJ	1
GALENKO, VE; GAVRILOVA, NA; SHISHOVA, OA; SKUIN', EIa	1
DONELLI, A	1
NESNIDALOVA, R; NEUWIRT, J; SKORPIL, V	1
DE MAIO, D	1
BARDONI, F; DEL GRECO, V	1
SELIGER, H	1
DELAY, J; PERSE, J; PICHOT, P; PUECH, J	1
PILE, WJ	1
THOMAS, J	1
Javitt, DC	1
Boksha, IS	1
Bennett, M; Mancini, C; Patterson, B; Van Ameringen, M	1
Buonopane, A; Petrakis, IL	1
Wang, SJ; Yang, TT	1
Chuhma, N; Conjard, A; Darmon, M; Foutz, AS; Hamon, M; Hen, R; Jorisch, R; Masson, J; Miller, GM; Parrot, S; Polan, J; Rayport, S; Ropert, N; Thoby-Brisson, M	1
Cepeda, C; Levine, MS	1
Kalivas, PW; Szumlinski, KK; Worley, PF	1
Takumi, T	1
Howland, RH	1
Archer, T; Beninger, RJ; Kostrzewa, RM; Palomo, T	1
Chen, MK; Guilarte, TR	1
Borioni, A; Calamandrei, G; Domenici, MR; Lastoria, G; Martire, A; Popoli, P; Potenza, RL; Scattoni, ML; Venerosi, A	1
Dennis, DM; Glushakov, AV; Gravenstein, N; Martynyuk, AE; Seubert, CN; Sumners, C; Yarotskyy, V	1
De Vries, TJ; Diergaarde, L; Schoffelmeer, AN	1
Walker, JE	1
Stahl, SM	1
Volpe, BT	1
Rye, DB	1
Farber, NB; Newcomer, JW; Olney, JW	1
Krishnamoorthy, ES; Trimble, MR	1
Nakamura, K	1

Reviews

46 review(s) available for glutamic acid and Mental Disorders

Article	Year
International journal of molecular sciences, 2022, Jan-23, Volume: 23, Issue:3 Topics: Animals; Brain; Brain Diseases; Brain Injuries, Traumatic; Dipeptides; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Mental Disorders; Neurodegenerative Diseases; Neurons; Neurotransmitter Agents; Receptors, Metabotropic Glutamate	2022
Tryptophan metabolism: Mechanism-oriented therapy for neurological and psychiatric disorders. Frontiers in immunology, 2022, Volume: 13 Topics: Dopamine; Glucocorticoids; Glutamic Acid; Humans; Mental Disorders; Receptors, Aryl Hydrocarbon; Receptors, Nicotinic; Tryptophan; Vitamins	2022
Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry, 2022, Volume: 28, Issue:5 Topics: Alzheimer Disease; Autism Spectrum Disorder; Glutamic Acid; Humans; Mental Disorders; Parkinson Disease	2022
Plasticity of the epigenome during early-life stress. Seminars in cell & developmental biology, 2018, Volume: 77 Topics: Age Factors; Animals; Brain-Derived Neurotrophic Factor; Disease Models, Animal; DNA Methylation; Epigenesis, Genetic; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Hypothalamo-Hypophyseal System; Mental Disorders; Mice; Pituitary-Adrenal System; Protein Processing, Post-Translational; Psychopathology; Rats; Resilience, Psychological; RNA, Untranslated; Serotonin; Signal Transduction; Stress, Psychological	2018
Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications. Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:3 Topics: Animals; Glutamic Acid; Humans; Mental Disorders; Nervous System Diseases; Neurons; Receptors, Glutamate	2018
Long-term cortical synaptic changes contribute to chronic pain and emotional disorders. Neuroscience letters, 2019, 05-29, Volume: 702 Topics: Adenylyl Cyclases; Animals; Brain; Chronic Pain; Emotions; Enzyme Activation; Genes, Immediate-Early; Glutamic Acid; Humans; Mental Disorders; Neuronal Plasticity; Phosphorylation; Protein Biosynthesis; Receptors, Cell Surface; Synapses	2019
Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches. Molecular neurobiology, 2014, Volume: 49, Issue:1 Topics: Animals; Antipsychotic Agents; Child Development Disorders, Pervasive; Dendritic Spines; Disks Large Homolog 4 Protein; Drug Delivery Systems; Glutamic Acid; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Mental Disorders; Nerve Tissue Proteins; Neuronal Plasticity; Schizophrenia; Synapses	2014
Kainate receptors in health and disease. Neuron, 2013, Oct-16, Volume: 80, Issue:2 Topics: Animals; Brain; Central Nervous System Diseases; Glutamic Acid; Health; Humans; Mental Disorders; Models, Neurological; Protein Binding; Receptors, Kainic Acid; Synaptic Transmission	2013
Use of proton magnetic resonance spectroscopy in the treatment of psychiatric disorders: a critical update. Dialogues in clinical neuroscience, 2013, Volume: 15, Issue:3 Topics: Animals; Brain; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders; Protons; Treatment Outcome	2013
Mental disturbances in Parkinson's disease and related disorders: the role of excitotoxins. Journal of Parkinson's disease, 2014, Volume: 4, Issue:2 Topics: Dopamine; Glutamic Acid; Humans; Kynurenine; Mental Disorders; Neuroprotective Agents; Neurotoxins; Parkinson Disease	2014
D-Serine in neurobiology: CNS neurotransmission and neuromodulation. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2014, Volume: 41, Issue:2 Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Central Nervous System; Epilepsy; Glutamic Acid; Humans; Hypoxia-Ischemia, Brain; Mental Disorders; Neurodegenerative Diseases; Neuronal Plasticity; Neurotransmitter Agents; Receptors, N-Methyl-D-Aspartate; Serine; Synaptic Transmission	2014
Preclinical pharmacology of amphetamine: implications for the treatment of neuropsychiatric disorders. Pharmacology & therapeutics, 2014, Volume: 143, Issue:3 Topics: Amphetamine; Animals; Biogenic Amines; Glutamic Acid; Humans; Mental Disorders; Opioid Peptides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Synaptic Transmission	2014
Glutamatergic dysregulation in pediatric psychiatric disorders: a systematic review of the magnetic resonance spectroscopy literature. The Journal of clinical psychiatry, 2014, Volume: 75, Issue:11 Topics: Adolescent; Brain; Child; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Mental Disorders	2014
Dynamics and modulation of metabotropic glutamate receptors. Current opinion in pharmacology, 2015, Volume: 20 Topics: Allosteric Regulation; Central Nervous System; Drug Design; Glutamic Acid; Humans; Ligands; Mental Disorders; Molecular Targeted Therapy; Nervous System Diseases; Receptors, Metabotropic Glutamate; Synaptic Transmission	2015
Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders. Current molecular medicine, 2015, Volume: 15, Issue:3 Topics: Animals; Antidepressive Agents; Dendritic Spines; Glutamic Acid; Humans; Mental Disorders; Neurogenesis; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptic Transmission	2015
Purinergic signaling and energy homeostasis in psychiatric disorders. Current molecular medicine, 2015, Volume: 15, Issue:3 Topics: Animals; Biological Transport; Energy Metabolism; Glutamic Acid; Homeostasis; Humans; Mental Disorders; Neuronal Plasticity; Receptors, Purinergic; Synapses; Synaptic Transmission	2015
Evaluation of neuron-glia integrity by in vivo proton magnetic resonance spectroscopy: Implications for psychiatric disorders. Neuroscience and biobehavioral reviews, 2016, Volume: 71 Topics: Brain; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders; Neuroglia; Neurons; Proton Magnetic Resonance Spectroscopy	2016
Psychiatric problems in patients infected with hepatitis C before and during antiviral treatment with interferon-alpha: a review. Journal of psychiatric practice, 2009, Volume: 15, Issue:4 Topics: Alleles; Antiviral Agents; Brain; Dopamine; Glutamic Acid; Health Education; Hepatitis C, Chronic; Humans; Hydrocortisone; Hyperthyroidism; Hypothalamo-Hypophyseal System; Hypothyroidism; Interferon-alpha; Mental Disorders; Patient Compliance; Pituitary-Adrenal System; Prevalence; Serotonin; Substance-Related Disorders	2009
[Role of glutamate transporters in the pathophysiology of major mental illnesses]. Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology, 2009, Volume: 29, Issue:4 Topics: Amino Acid Transport System X-AG; Animals; Brain; Disease Models, Animal; Down-Regulation; Glutamic Acid; Humans; Mental Disorders; Mice; Neuroglia; Neurons; Neurotransmitter Agents; Signal Transduction; Synaptic Transmission	2009
[Molecular operation of ionotropic glutamate receptors: proteins that mediate the excitatory synaptic neurotransmission]. Medecine sciences : M/S, 2010, Volume: 26, Issue:1 Topics: Allosteric Regulation; Cations; Central Nervous System Agents; Dimerization; Drug Design; Excitatory Amino Acid Agonists; Glutamic Acid; Humans; Ion Channel Gating; Mental Disorders; Models, Molecular; Neurodegenerative Diseases; Protein Conformation; Protein Subunits; Receptors, Glutamate; Receptors, Presynaptic; Substrate Specificity; Synaptic Transmission	2010
Hippocampal kainate receptors. Vitamins and hormones, 2010, Volume: 82 Topics: Animals; Epilepsy; Glutamic Acid; Hippocampus; Humans; Mental Disorders; Neuronal Plasticity; Rats; Receptors, Kainic Acid	2010
Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2011, Volume: 36, Issue:1 Topics: Animals; Avoidance Learning; Disease Models, Animal; Excitatory Amino Acid Antagonists; Extinction, Psychological; Glutamic Acid; Humans; Mental Disorders; Receptors, Glutamate; Stress Disorders, Post-Traumatic; Substance-Related Disorders	2011
Selective GABA release as a mechanistic basis of high-frequency stimulation used for the treatment of neuropsychiatric diseases. Naunyn-Schmiedeberg's archives of pharmacology, 2011, Volume: 384, Issue:1 Topics: Animals; Central Nervous System Diseases; Deep Brain Stimulation; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Mental Disorders	2011
Glutamatergic medications for the treatment of drug and behavioral addictions. Pharmacology, biochemistry, and behavior, 2012, Volume: 100, Issue:4 Topics: Animals; Glutamic Acid; Humans; Mental Disorders; Substance-Related Disorders	2012
Analysis of free D-serine in mammals and its biological relevance. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2011, Nov-01, Volume: 879, Issue:29 Topics: Animals; Brain; Brain Chemistry; Glutamic Acid; Humans; Mental Disorders; Receptors, N-Methyl-D-Aspartate; Serine; Stereoisomerism	2011
MR spectroscopic studies of the brain in psychiatric disorders. Current topics in behavioral neurosciences, 2012, Volume: 11 Topics: Aspartic Acid; Brain; Creatine; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Mental Disorders	2012
Diversity of metabotropic glutamate receptor-interacting proteins and pathophysiological functions. Advances in experimental medicine and biology, 2012, Volume: 970 Topics: Animals; Carrier Proteins; Genetic Heterogeneity; Glutamic Acid; GTP-Binding Proteins; Homer Scaffolding Proteins; Humans; Mammals; Mental Disorders; Mice; Neurodegenerative Diseases; Neurons; Post-Synaptic Density; Protein Binding; Receptors, Metabotropic Glutamate; Synaptic Transmission	2012
Minocycline: therapeutic potential in psychiatry. CNS drugs, 2012, May-01, Volume: 26, Issue:5 Topics: Animals; Anti-Bacterial Agents; Drug Delivery Systems; Glutamic Acid; Humans; Inflammation; Mental Disorders; Minocycline; Nerve Growth Factors; Oxidative Stress	2012
Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling. Pharmacological reviews, 2012, Volume: 64, Issue:3 Topics: Amino Acid Transport System y+; Animals; Biological Transport; Central Nervous System; Cystine; Glutamic Acid; Glutathione; Humans; Mental Disorders; Neurodegenerative Diseases; Neurotoxicity Syndromes; Signal Transduction; Synapses	2012
Glutamate as a therapeutic target in psychiatric disorders. Molecular psychiatry, 2004, Volume: 9, Issue:11 Topics: Animals; Disease Models, Animal; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Phencyclidine; Receptors, Glutamate; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Schizophrenia	2004
Coupling between neuronal and glial cells via glutamate metabolism in brain of healthy persons and patients with mental disorders. Biochemistry. Biokhimiia, 2004, Volume: 69, Issue:7 Topics: Brain; Glutamic Acid; Humans; Mental Disorders; Models, Biological; Neuroglia; Neurons	2004
Pharmacotherapy of alcohol use disorders. Substance use & misuse, 2005, Volume: 40, Issue:13-14 Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Amitriptyline; Antidepressive Agents, Tricyclic; Comorbidity; Disulfiram; Dopamine; Drug Interactions; Ethanol; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Male; Mental Disorders; Naltrexone; Narcotics; Serotonin; Taurine	2005
Role of central glutamatergic neurotransmission in the pathogenesis of psychiatric and behavioral disorders. Drug news & perspectives, 2005, Volume: 18, Issue:9 Topics: Animals; Antipsychotic Agents; Brain; Dopamine; Glutamic Acid; Humans; Mental Disorders; Receptors, Glutamate; Schizophrenia; Synaptic Transmission	2005
Where do you think you are going? The NMDA-D1 receptor trap. Science's STKE : signal transduction knowledge environment, 2006, May-02, Volume: 2006, Issue:333 Topics: Allosteric Regulation; Animals; Antipsychotic Agents; Calcium; Corpus Striatum; Diffusion; Dopamine; Drug Design; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Models, Neurological; N-Methylaspartate; Nervous System Diseases; Neurons; Organ Culture Techniques; Protein Interaction Mapping; Protein Subunits; Protein Transport; Rats; Receptors, Dopamine D1; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Synaptic Membranes	2006
Homer proteins: implications for neuropsychiatric disorders. Current opinion in neurobiology, 2006, Volume: 16, Issue:3 Topics: Animals; Brain; Carrier Proteins; Genetic Predisposition to Disease; Glutamic Acid; Homer Scaffolding Proteins; Humans; Mental Disorders; Neural Pathways; Polymorphism, Genetic; Protein Isoforms; Synaptic Transmission	2006
[Biological anomalies of mental diseases are located in spines?]. Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 2006, Volume: 51, Issue:15 Topics: Animals; Dendritic Spines; Glutamic Acid; Humans; Intracellular Signaling Peptides and Proteins; Mental Disorders; Mice; Mice, Knockout; Myosin Type V; Protein Transport; Proteins; RNA-Binding Protein FUS; RNA, Messenger; Signal Transduction	2006
Glutamate-modulating drugs & the treatment of mental disorders. Journal of psychosocial nursing and mental health services, 2007, Volume: 45, Issue:1 Topics: Acamprosate; Amantadine; Cycloserine; Glutamic Acid; Humans; Ketamine; Lamotrigine; Memantine; Mental Disorders; Psychotropic Drugs; Riluzole; Taurine; Triazines	2007
Comorbidity of substance abuse with other psychiatric disorders. Neurotoxicity research, 2007, Volume: 12, Issue:1 Topics: Cerebral Ventricles; Comorbidity; Glutamic Acid; Humans; Mental Disorders; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders; Synaptic Transmission	2007
Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders. Recent patents on CNS drug discovery, 2006, Volume: 1, Issue:3 Topics: Animals; Brain; Brain Diseases; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Hydroxyl Radical; Mental Disorders; Neuroprotective Agents; Phenylalanine; Synaptic Transmission; Tyrosine	2006
Pharmacological manipulation of memory reconsolidation: towards a novel treatment of pathogenic memories. European journal of pharmacology, 2008, May-13, Volume: 585, Issue:2-3 Topics: Acetylcholine; Animals; Behavior, Addictive; Cannabinoid Receptor Modulators; Dopamine; Glucocorticoids; Glutamic Acid; Humans; Memory; Mental Disorders; Neurotransmitter Agents; Norepinephrine; Stress Disorders, Post-Traumatic	2008
Glutamate, GABA, and CNS disease: a review. Neurochemical research, 1983, Volume: 8, Issue:4 Topics: Brain; Brain Diseases; Energy Metabolism; Epilepsy; Ethanol; gamma-Aminobutyric Acid; Glutamates; Glutamic Acid; Humans; Kindling, Neurologic; Mental Disorders; Neurons; Neurotransmitter Agents; Receptors, Cell Surface; Receptors, GABA-A; Receptors, Glutamate; Synapses	1983
Delayed neuronal degeneration results from endogenous glutamate excess. Possible role in NP-SLE. Annals of the New York Academy of Sciences, 1997, Aug-14, Volume: 823 Topics: Animals; Glutamic Acid; Humans; Lupus Erythematosus, Systemic; Mental Disorders; Nerve Degeneration; Nervous System Diseases; Time Factors	1997
Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep, 1997, Volume: 20, Issue:9 Topics: Acetylcholine; Arousal; Basal Ganglia; Brain Stem; Evoked Potentials, Auditory; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Mental Disorders; Neurodegenerative Diseases; Neurons, Afferent; Neurons, Efferent; Receptors, Muscarinic; Sleep Wake Disorders; Sleep, REM	1997
The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer's disease. Progress in brain research, 1998, Volume: 116 Topics: Alzheimer Disease; Animals; Glutamic Acid; Humans; Mental Disorders; Schizophrenia; Synapses	1998
Forced normalization: clinical and therapeutic relevance. Epilepsia, 1999, Volume: 40 Suppl 10 Topics: Animals; Cats; Cerebral Cortex; Comorbidity; Diagnosis, Differential; Dopamine; Electroencephalography; Epilepsy; Functional Laterality; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Kindling, Neurologic; Mental Disorders; Neurotransmitter Agents; Psychotic Disorders	1999
Aniracetam: its novel therapeutic potential in cerebral dysfunctional disorders based on recent pharmacological discoveries. CNS drug reviews, 2002,Spring, Volume: 8, Issue:1 Topics: Acetylcholine; Animals; Biogenic Monoamines; Brain; Brain Diseases; Cognition Disorders; Glutamic Acid; Mental Disorders; Nootropic Agents; Pyrrolidinones; Signal Transduction	2002

Other Studies

44 other study(ies) available for glutamic acid and Mental Disorders

Article	Year
Acute stress and alcohol exposure during adolescence result in an anxious phenotype in adulthood: Role of altered glutamate/endocannabinoid transmission mechanisms. Progress in neuro-psychopharmacology & biological psychiatry, 2022, 03-08, Volume: 113 Topics: Alcoholism; Amygdala; Animals; Anxiety; Endocannabinoids; Glutamic Acid; Male; Mental Disorders; Phenotype; Rats; Rats, Wistar; Receptors, Metabotropic Glutamate; Signal Transduction; Stress, Physiological	2022
Subanesthetic ketamine with an AMPAkine attenuates motor impulsivity in rats. Behavioural pharmacology, 2021, 06-01, Volume: 32, Issue:4 Topics: Animals; Antidepressive Agents; Cognition; Dose-Response Relationship, Drug; Glutamic Acid; Impulsive Behavior; Ketamine; Mental Disorders; Neuronal Plasticity; Nootropic Agents; Piracetam; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission	2021
Social preference is maintained in mice with impaired startle reflex and glutamate/D-serine imbalance induced by chronic cerebral toxoplasmosis. Scientific reports, 2021, 07-07, Volume: 11, Issue:1 Topics: Animals; Behavior, Animal; Body Weight; Brain; Glutamic Acid; Hippocampus; Mental Disorders; Mice; Neurotransmitter Agents; Prefrontal Cortex; Reflex, Startle; Serine; Social Behavior; Toxoplasma; Toxoplasmosis, Cerebral	2021
Glutamate and norepinephrine interaction: Relevance to higher cognitive operations and psychopathology. The Behavioral and brain sciences, 2016, Volume: 39 Topics: Arousal; Cognition; Glutamic Acid; Humans; Mental Disorders; Norepinephrine	2016
Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex. Proceedings of the National Academy of Sciences of the United States of America, 2018, 03-06, Volume: 115, Issue:10 Topics: Animals; Behavior, Animal; Glutamic Acid; Intracellular Signaling Peptides and Proteins; Mental Disorders; Mice; Mice, Transgenic; Neuregulins; Pyramidal Cells; SNARE Proteins	2018
THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Translational psychiatry, 2018, 04-25, Volume: 8, Issue:1 Topics: Autistic Disorder; Base Sequence; Dronabinol; Gene Expression Profiling; Gene Expression Regulation; Glutamic Acid; Humans; Induced Pluripotent Stem Cells; Intellectual Disability; Mental Disorders; Mitochondria; Neurons; Post-Synaptic Density; Schizophrenia; Transcriptome	2018
Synaptic phospholipids as a new target for cortical hyperexcitability and E/I balance in psychiatric disorders. Molecular psychiatry, 2018, Volume: 23, Issue:8 Topics: Animals; Astrocytes; Cells, Cultured; Central Nervous System Agents; Cerebral Cortex; Disease Models, Animal; Glutamic Acid; Humans; Ketamine; Lysophospholipids; Mental Disorders; Mice, Inbred C57BL; Mice, Transgenic; Neural Inhibition; Phosphoric Diester Hydrolases; Proteoglycans; Psychotropic Drugs; Synapses; Tissue Culture Techniques; Vesicular Transport Proteins	2018
Psychiatric risk gene Cacna1c determines mitochondrial resilience against oxidative stress in neurons. Cell death & disease, 2018, 05-29, Volume: 9, Issue:6 Topics: Animals; Calcium Channels, L-Type; Genetic Predisposition to Disease; Glutamic Acid; Mental Disorders; Mitochondria; Neurons; Oxidative Stress; Risk Factors	2018
The Protein Biochemistry of the Postsynaptic Density in Glutamatergic Synapses Mediates Learning in Neural Networks. Biochemistry, 2018, 07-10, Volume: 57, Issue:27 Topics: Animals; Glutamic Acid; Humans; Long-Term Potentiation; Mental Disorders; Mutation; Nerve Net; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuronal Plasticity; Post-Synaptic Density	2018
Special Issue on Disease: New Advances in Psychiatry. Neuron, 2019, 04-03, Volume: 102, Issue:1 Topics: Animals; Brain; Cerebellum; Depression, Postpartum; Depressive Disorder; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Mental Disorders; Neural Pathways; Neuropsychiatry; Obsessive-Compulsive Disorder; Pregnancy; Pregnancy Complications; Primates; Psychiatry; Stress Disorders, Post-Traumatic; Substance-Related Disorders	2019
The glutamate system as a therapeutic target and impact of genes on suicidality. European archives of psychiatry and clinical neuroscience, 2013, Volume: 263, Issue:5 Topics: Glutamic Acid; Humans; Mental Disorders; Receptors, Glutamate; Suicide	2013
Neuropharmacological and neurobiological relevance of in vivo ¹H-MRS of GABA and glutamate for preclinical drug discovery in mental disorders. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014, Volume: 39, Issue:10 Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Discovery; Excitatory Amino Acid Agents; GABA Agents; gamma-Aminobutyric Acid; Glutamic Acid; Male; Mental Disorders; Proton Magnetic Resonance Spectroscopy; Rats, Sprague-Dawley; Reproducibility of Results	2014
All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Molecular psychiatry, 2017, Volume: 22, Issue:12 Topics: Aged; Animals; Autoantibodies; Endocytosis; Epitopes; Female; Fibroblasts; Glutamic Acid; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglobulin M; Induced Pluripotent Stem Cells; Male; Membrane Potentials; Mental Disorders; Middle Aged; Nervous System Diseases; Neurons; Oocytes; Receptors, N-Methyl-D-Aspartate; Xenopus laevis	2017
Astroglia, Glutamatergic Transmission and Psychiatric Diseases. Advances in neurobiology, 2016, Volume: 13 Topics: Astrocytes; Glutamic Acid; Glutamine; Humans; Mental Disorders; Neurons; Synaptic Transmission	2016
A study of glutamate levels, NR1, NR2A, NR2B receptors and oxidative stress in rat model of Japanese encephalitis. Physiology & behavior, 2017, 03-15, Volume: 171 Topics: Analysis of Variance; Animals; Brain; Disease Models, Animal; Encephalitis Virus, Japanese; Encephalitis, Japanese; Gene Expression Regulation, Viral; Glutamic Acid; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Locomotion; Mental Disorders; Muscle Strength; Oxidative Stress; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; RNA, Messenger; Time Factors	2017
The Youth Mental Health Risk and Resilience Study (YouR-Study). BMC psychiatry, 2017, 01-26, Volume: 17, Issue:1 Topics: Adolescent; Adult; Biomarkers; Brain; Clinical Protocols; Early Diagnosis; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Magnetoencephalography; Male; Mental Disorders; Neuropsychological Tests; Psychotic Disorders; Resilience, Psychological; Risk Factors; Young Adult	2017
Clinical NOE 13C MRS for neuropsychiatric disorders of the frontal lobe. Journal of magnetic resonance (San Diego, Calif. : 1997), 2008, Volume: 195, Issue:2 Topics: Biomarkers; Brain; Carbon Isotopes; Frontal Lobe; Glutamic Acid; Humans; Magnetic Resonance Spectroscopy; Mental Disorders; Reproducibility of Results; Sensitivity and Specificity	2008
Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biological psychiatry, 2009, Sep-15, Volume: 66, Issue:6 Topics: Adult; Brain Mapping; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Disorders; Protons; Psychiatric Status Rating Scales; Risk; Temporal Lobe; Thalamus; Young Adult	2009
Susceptibility to stress in young rats after 2-week zinc deprivation. Neurochemistry international, 2010, Volume: 56, Issue:3 Topics: Animals; Brain Chemistry; Corticosterone; Depressive Disorder; Dietary Supplements; Disease Models, Animal; Exocytosis; Fluorescent Dyes; Glutamic Acid; Hippocampus; Male; Mental Disorders; Neurons; Neuropsychological Tests; Potassium Chloride; Pyridinium Compounds; Quaternary Ammonium Compounds; Rats; Rats, Wistar; Stress, Psychological; Up-Regulation; Zinc	2010
Editorial: Etiological hypotheses of mental disorders at the molecular level. The Israel journal of psychiatry and related sciences, 2010, Volume: 47, Issue:1 Topics: Bipolar Disorder; Circadian Rhythm; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Mental Disorders; Receptors, N-Methyl-D-Aspartate; Risk Factors; Schizophrenia; Sleep	2010
Psychiatric drugs. Excited by glutamate. Science (New York, N.Y.), 2003, Jun-20, Volume: 300, Issue:5627 Topics: Animals; Anxiety Disorders; Brain; Brain Diseases; Bridged Bicyclo Compounds; Clinical Trials as Topic; Depressive Disorder; Dopamine; Excitatory Amino Acid Agents; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Mental Disorders; Neurons; Pain; Receptors, Glutamate; Receptors, Metabotropic Glutamate; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Substance-Related Disorders; Synaptic Transmission	2003
[The importance of the glutamatergic system in neuropsychiatric diseases]. Fortschritte der Neurologie-Psychiatrie, 2003, Volume: 71 Suppl 1 Topics: Glutamic Acid; Humans; Mental Disorders; Nervous System Diseases	2003
[Therapy of mental disorders in children and glutamic acid]. Prakticky lekar, 1953, Jan-20, Volume: 33, Issue:2 Topics: Diet, Reducing; Glutamates; Glutamic Acid; Intellectual Disability; Mental Disorders	1953
[Treatments with glutamic acid]. Munchener medizinische Wochenschrift (1950), 1953, Aug-21, Volume: 95, Issue:34 Topics: Electroconvulsive Therapy; Glutamates; Glutamic Acid; Mental Disorders; Psychosurgery; Psychotherapy	1953
[The mixture of dextrorotatory amphetamine-glutamic acid in neuro-psychiatry; clinical results]. Gazette medicale de France, 1954, Volume: 61, Issue:4 Topics: Amphetamine; Amphetamines; Glutamates; Glutamic Acid; Mental Disorders; Psychiatry; Psychosurgery; Psychotherapy	1954
[The response of the blood sugar to 1+-glutamic acid and its effect on delayed awakening and on the so-called irreversible coma in insulin treatments of mental patients]. Arztliche Forschung, 1954, Sep-10, Volume: 8, Issue:9 Topics: Blood Glucose; Brain Death; Convulsive Therapy; Electroconvulsive Therapy; Glutamates; Glutamic Acid; Humans; Insulin; Mental Disorders; Mentally Ill Persons; Psychosurgery	1954
[Glutamic acid therapy in child psychiatry]. Orvosi hetilap, 1954, Aug-01, Volume: 95, Issue:31 Topics: Child; Child Psychiatry; Glutamates; Glutamic Acid; Humans; Infant; Mental Disorders	1954
[Treatment of myasthenia gravis and of mental disorders in chorea minor with glutamic acid]. Munchener medizinische Wochenschrift (1950), 1954, Oct-15, Volume: 96, Issue:42 Topics: Chorea; Glutamates; Glutamic Acid; Humans; Mental Disorders; Myasthenia Gravis	1954
[Result of application of glutamic acid in psychiatric practice]. Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1955, Volume: 55, Issue:11 Topics: Electroconvulsive Therapy; Glutamates; Glutamic Acid; Mental Disorders; Psychosurgery; Psychotherapy	1955
[Clinical and psychological data on therapeutics of oligophrenia in children; treatment with a preparation of glutamic acid, ditetraethylammonium phosphate and vitamin B1]. Gazzetta medica italiana, 1957, Volume: 116, Issue:3 Topics: Coal Tar; Diet, Reducing; Glutamates; Glutamic Acid; Intellectual Disability; Mental Disorders; Phosphates; Tetraethylammonium; Thiamine	1957
[Significance of glutamic acid for the nervous system]. Ceskoslovenska psychiatrie, 1957, Volume: 53, Issue:2 Topics: Electroconvulsive Therapy; Glutamates; Glutamic Acid; Mental Disorders; Nervous System; Psychosurgery; Psychotherapy	1957
[Glutamic treatment in certain psychic complications of chronic alcoholism (predelerium & delirium tremens); concerning the gamma-ethyl ester of glutamic acid]. Gazzetta medica italiana, 1957, Volume: 116, Issue:12 Topics: Alcohol Withdrawal Delirium; Alcoholism; Esters; Glutamates; Glutamic Acid; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders	1957
[Several cases of alcoholic and amential psychoses treated with a glutamic acid derivative]. Rivista di patologia nervosa e mentale, 1959, Volume: 80 Topics: Dementia; Glutamates; Glutamic Acid; Humans; Mental Disorders; Psychoses, Alcoholic; Psychotic Disorders	1959
[On the efficacy mechanism of glutamic acid and their clinical effects especially in mental disorders, and diseases of the nervous system]. Arztliche Wochenschrift, 1951, Jan-19, Volume: 6, Issue:3 Topics: Central Nervous System Depressants; Glutamic Acid; Humans; Mental Disorders; Nervous System; Psychotic Disorders	1951
[Glutamic acid in psychiatry]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1951, Jul-02, Volume: 27, Issue:49 Topics: Glutamic Acid; Humans; Mental Disorders; Psychiatry; Psychotic Disorders	1951
[Glutamic acid in therapy of certain psychiatric diseases]. Medecine et hygiene, 1951, Sep-01, Volume: 9, Issue:201 Topics: Electroconvulsive Therapy; Glutamates; Glutamic Acid; Mental Disorders; Psychosurgery; Psychotherapy; Psychotic Disorders	1951
Effect of glutamic acid on chronic psychotic patients. Diseases of the nervous system, 1952, Volume: 13, Issue:4 Topics: Electroconvulsive Therapy; Glutamates; Glutamic Acid; Mental Disorders; Psychosurgery; Psychotherapy	1952
[Studies on the effect of glutamic acid in brain injury sequels]. Medizinische Klinik, 1952, Mar-21, Volume: 47, Issue:12 Topics: Brain; Brain Injuries; Glutamates; Glutamic Acid; Humans; Mental Disorders; Psychotherapy	1952
Topiramate augmentation in treatment-resistant obsessive-compulsive disorder: a retrospective, open-label case series. Depression and anxiety, 2006, Volume: 23, Issue:1 Topics: Adult; Anticonvulsants; Antipsychotic Agents; Anxiety Disorders; Caudate Nucleus; Drug Resistance; Drug Synergism; Female; Fructose; Glutamic Acid; Humans; Male; Mental Disorders; Middle Aged; Obsessive-Compulsive Disorder; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Topiramate	2006
[Also consider non-cognitive disorders]. Krankenpflege Journal, 2005, Volume: 43, Issue:7-10 Topics: Aged; Alzheimer Disease; Brain; Cognition Disorders; Depressive Disorder; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Memantine; Mental Disorders; Treatment Outcome	2005
Mice lacking brain/kidney phosphate-activated glutaminase have impaired glutamatergic synaptic transmission, altered breathing, disorganized goal-directed behavior and die shortly after birth. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2006, Apr-26, Volume: 26, Issue:17 Topics: Animals; Animals, Newborn; Brain; Glutamic Acid; Glutaminase; Goals; Hypoventilation; Kidney; Mental Disorders; Mice; Mice, Knockout; Neural Pathways; Respiration Disorders; Respiratory Mechanics; Survival Rate; Synaptic Transmission	2006
Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology, 2007, Volume: 28, Issue:6 Topics: Animals; Binding, Competitive; Brain; Cell Membrane; Cognition; Copper Sulfate; Dizocilpine Maleate; Dose-Response Relationship, Drug; Glutamic Acid; Glycine; In Vitro Techniques; Kinetics; Male; Manganese Compounds; Mental Disorders; Neurons; Rats; Rats, Long-Evans; Receptors, N-Methyl-D-Aspartate; Sulfates; Tritium	2007
Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice. Neurobiology of disease, 2007, Volume: 28, Issue:2 Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Brain; Corpus Striatum; Disease Models, Animal; Excitatory Amino Acid Agonists; Glutamic Acid; Huntington Disease; Learning Disabilities; Maze Learning; Mental Disorders; Mice; Mice, Transgenic; Motor Activity; Neuroprotective Agents; Organ Culture Techniques; Pyrimidines; Receptor, Adenosine A2A; Triazoles	2007
Excitotoxicity and neuroprotection. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:6 Topics: Brain Diseases; Calcium; Cell Death; Excitatory Amino Acid Antagonists; Free Radical Scavengers; Glutamic Acid; Humans; Mental Disorders; Neurons; Neuroprotective Agents; Receptors, N-Methyl-D-Aspartate; Synaptic Transmission	1997